[Home ] [Archive]    
:: Main :: About :: Current Issue :: Archive :: Search :: Submit :: Contact ::
Main Menu
IJRR Information::
For Authors::
For Reviewers::
News & Events::
Web Mail::
Search in website

Advanced Search
Receive site information
Enter your Email in the following box to receive the site news and information.
Hard Copy 2322-3243
Online 2345-4229
Online Submission
Now you can send your articles to IJRR office using the article submission system.



:: Volume 20, Issue 4 (10-2022) ::
Int J Radiat Res 2022, 20(4): 865-869 Back to browse issues page
Clinical efficacy of hyperthermic intraperitoneal chemotherapy on the malignant ascites in gastric cancer patients following the preoperative radiotherapy
Z. Wang , P. Wang , L. Lv , Y. Liu , C.J. Sun
Abstract:   (729 Views)
Background: To investigate the clinical efficacy of hyperthermic intraperitoneal chemotherapy in combination with the malignant ascites in gastric cancer following the Intensive preoperative radiotherapy for radical surgery of tumor. Materials and Methods: We selected a total of 112 gastric cancer patients who had been operated on for radical surgery of tumor in this hospital as subjects that were randomized into the control group and the observation group, with 56 patients in each group. Patients in the control group took the abdominal aspiration in combination with the intravenous chemotherapy, while those in the observation group underwent the hyperthermic intraperitoneal chemotherapy. After treatment, we compared the effectiveness rate, levels of tumor markers, incidence rates of adverse reactions, and  Karnofsky (KPS) scores between the two groups. Results: In the observation group and the control group, the effectiveness rates of patients were 71.43% and 44.64%, showing the statistical significance of the difference (P < 0.05); after treatment, the levels of CEA, CA125, and CA199, tumor markers, were decreased compared to before treatment (P < 0.05). The incidence rates of adverse reactions were 75.00% and 82.14%, showing no statistical significance of difference (P > 0.05). Following the treatment, the KPS scores were improved in two groups compared to before treatment (P < 0.05). Conclusion: For gastric cancer patients with malignant ascites, hyperthermic intraperitoneal chemotherapy excels in the clinical efficacy by decreasing the level of tumor markers, to improve the life quality of patients, but with no increase in the incidence rate of adverse reactions.
Keywords: Pelvis, Environmental radioactivity, internal hazard, gamma emitters, NaI (Tl), soil, Najaf schools.
Full-Text [PDF 530 kb]   (760 Downloads)    
Type of Study: Original Research | Subject: Radiation Biology
1. Japanese gastric cancer treatment guidelines 2014(ver.4) (2017). Gastric Cancer, 20(1): 1-19. [DOI:10.1007/s10120-016-0622-4] [PMID] []
2. Amoeba M and Peek RM Jr (2016) Pathobiology of helicobacter pylori induced gastric cancer.Gastroenterology, 150(1): 64-78. [DOI:10.1053/j.gastro.2015.09.004] [PMID] []
3. Hu JK and Chen XZ (2011) Reasonable choice and evaluation of treatment for advanced gastric cancer. Chinese Journal of Practical Surgery, 31(8): 720-722.
4. Magnone S, Allievi N, Pisano M, Piazzalunga D, Poiasina E, Campanati L, Poletti E, Allegri A, Manfredi R, Messina V, Paderno N (2020) Long term survival after CytoReductive Surgery and Hyperthermic IntraPeritoneal Chemotherapy (HIPEC) for advanced gastric cancer: a single center experience. European Journal of Surgical Oncology, 46(2): e144-5. [DOI:10.1016/j.ejso.2019.11.379]
5. DE Bree EE, Katsougkri D, Polioudaki H, Tsangaridou E, Michelakis D, Zoras O, Theodoropoulos P (2020) Hyperthermia during intraperitoneal chemotherapy with paclitaxel or docetaxel for ovarian cancer: Is there any benefit? Anticancer Research, 40(12): 6769-80. [DOI:10.21873/anticanres.14700] [PMID]
6. Tan JW, Tan GH, Ng WY, Ong CA, Chia CS, Soo KC, Teo MC (2020) High-grade complication is associated with poor overall survival after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Int J Clin oncol, 25(5): 984-994. [DOI:10.1007/s10147-019-01609-5] [PMID]
7. Xie TY, Di Wu SL, Qiu ZY, Song QY, Guan D, Wang LP, Li XG, Duan F, Wang XX (2020) Role of prophylactic hyperthermic intraperitoneal chemotherapy in patients with locally advanced gastric cancer. World Journal of Gastrointestinal Oncology, 12(7): 782. [DOI:10.4251/wjgo.v12.i7.782] [PMID] []
8. Friedrich M, Zinn W, Kolnsberg L, Kraft C, Kuhn W (2020) Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for Ovarian Cancer: Evaluation of side effects in a single institution Cohort. Anticancer Research, 40(3): 1481-6. [DOI:10.21873/anticanres.14092] [PMID]
9. Coccolini F, Campanati L, Catena F, Ceni V, Ceresoli M, Cruz JJ, Lotti M, Magnone S, Napoli J, Rossetti D, De Iaco P (2015) Hyperthermic intraperitoneal chemotherapy with cisplatin and paclitaxel in advanced ovarian cancer: a multicenter prospective observational study. Journal of Gynecologic Oncology, 26(1): 54. [DOI:10.3802/jgo.2015.26.1.54] [PMID] []
10. Ma CH, Fang LM, Chen R (2017) Application of compound sophora flavescens injection in cisplatin intraperitoneal perfusion chemotherapy for patients with malignant ascites of gastric cancer and its effect on immune function. Chinese Journal of Biochemical Medicine, 37(2): 109-112.
11. Zhou DF, Zhang J, Zhu ZG (2010) Targeted inhibition of Her2 in the treatment of gastric cancer. World Chinese Journal of Digestion, 18(34): 3648-3655. [DOI:10.11569/wcjd.v18.i34.3648]
12. Yang GX (2014) Effect of intravenous astragalus polysaccharide combined with cisplatin intraperitoneal chemotherapy on malignant ascites of gastric cancer. Hebei Journal of Traditional Chinese Medicine, 29 (2): 47-49.
13. Shchepotin IB, Evans SR, Chorny V, Osinsky S, Buras RR, Maligonov P, Shabahang M, Nauta RJ (1994) Intensive preoperative radiotherapy with local hyperthermia for the treatment of gastric carcinoma. Surgical Oncology, 3(1): 37-44. [DOI:10.1016/0960-7404(94)90022-1]
14. Guo L, Wang X, Ma B, Yang K, Zhang Q, Ye X, Luo H, Liu R (2011) Radiotherapy combined with surgical treatment for gastric cancer: a meta-analysis. The Chinese-German Journal of Clinical Oncology, 10(8): 442. [DOI:10.1007/s10330-011-0827-2]
15. Wong RK, Jang R, Darling G (2015) Postoperative chemoradiotherapy vs. preoperative chemoradiotherapy for locally advanced (operable) gastric cancer: clarifying the role and technique of radiotherapy. Journal of Gastrointestinal Oncology, 6(1): 89.
16. Joy P,Prithishkumar IJ,Isaac B(2017) Clinical anatomy of the inferior epigastric artery with special relevance to invasive procedures of the anterior abdominal wall.J Minim Access Surg, 13(1): 18-21. [DOI:10.4103/0972-9941.181331] [PMID] []
17. Rijckborst V,Ter Borg MJ,Tjwa ET,et al. (2016). Short article: Management of ruptured hepatocellular carcinoma in a European tertiary care center.Eur J Gastroenterol Hepatol, 28(8): 963-966. [DOI:10.1097/MEG.0000000000000652] [PMID]
18. Zheng L, Guo CY, Li HL, et al. (2013) Controlled study of transcatheter arterial chemoembolization combined with radiofrequency ablation in the treatment of primary hepatocellular carcinoma. Journal of Clinical Radiology, 32(7): 1032-1035.
19. Liu FZ, Liu XM, Liu F, et al. (2012) Application of a new type of hyperthermic perfusion machine and device in intraperitoneal hyperthermic perfusion chemotherapy for 21 cases of ovarian cancer during operation. Journal of Practical Gynecology and Obstetrics, 28(10): 834-837.
20. Colombo C,Baratti D,Kusamura S,et al. (2015) The role of hyperthermic intraperitoneal chemotherapy (HIPEC) and isolated perfusion (ILP) interventions in sarcoma. J Surg Oncol, 111(5): 570-579. [DOI:10.1002/jso.23808] [PMID]
21. Yin SL, Liu Y, Shi H, et al. (2012) Effect of systemic chemotherapy plus pirarubicin hyperthermic perfusion chemotherapy on patients with advanced bladder cancer and the effect of nursing intervention on quality of life. Chinese Journal of Gerontology, 32(16): 3416-3418.
22. Cooper R, Newman P, Herachwati N (2018) RAPD Molecular Markers to Analyze the DNA Variation of the Three Bruguiera Species on Kemujan Island. Ccamlr Science, 25(3): 209-214.
23. Meng SY and Young B (2018) Effects of Vitamin D Addition Levels on Growth Performance, Body Composition and Serum Biochemical Parameters of Mid-Term Tilapia. Ccamlr Science, 25(2): 97-105.
24. Patriti A, Cavazzoni E, Graziosi L, Pisciaroli A, Luzi D, Gullà N, Donini A (2008) Successful palliation of malignant ascites from peritoneal mesothelioma by laparoscopic intraperitoneal hyperthermic chemotherapy. Surgical Laparoscopy Endoscopy & Percutaneous Techniques, 18(4): 426-8. [DOI:10.1097/SLE.0b013e318173a61e] [PMID]
25. Benoit L, Cheynel N, Ortega-Deballon P, Di Giacomo G, Chauffert B, Rat P (2008) Closed hyperthermic intraperitoneal chemotherapy with open abdomen: a novel technique to reduce exposure of the surgical team to chemotherapy drugs. Annals of Surgical Oncology, 15(2): 542-6. [DOI:10.1245/s10434-007-9635-x] [PMID] []
26. Facchiano E, Scaringi S, Kianmanesh R, Sabate JM, Castel B, Flamant Y, Coffin B, Msika S (2008) Laparoscopic hyperthermic intraperitoneal chemotherapy (HIPEC) for the treatment of malignant ascites secondary to unrespectable peritoneal carcinomatosis from advanced gastric cancer. European Journal of Surgical Oncology (EJSO), 34(2): 154-8. [DOI:10.1016/j.ejso.2007.05.015] [PMID]
27. Ba MC, Cui SZ, Lin SQ, Tang YQ, Wu YB, Wang B, Zhang XL (2010) Chemotherapy with laparoscope-assisted continuous circulatory hyperthermic intraperitoneal perfusion for malignant ascites. World Journal of Gastroenterology: WJG, 16(15): 1901. [DOI:10.3748/wjg.v16.i15.1901] [PMID] []
28. Valle M, Van der Speeten K, Garofalo A (2009) Laparoscopic hyperthermic intraperitoneal preoperative chemotherapy (HIPEC) in the management of refractory malignant ascites: A multi‐institutional retrospective analysis in 52 patients. Journal of Surgical Oncology, 100(4):331-4. [DOI:10.1002/jso.21321] [PMID]
Add your comments about this article
Your username or Email:


XML     Print

Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Wang Z, Wang P, Lv L, Liu Y, Sun C. Clinical efficacy of hyperthermic intraperitoneal chemotherapy on the malignant ascites in gastric cancer patients following the preoperative radiotherapy. Int J Radiat Res 2022; 20 (4) :865-869
URL: http://ijrr.com/article-1-4493-en.html

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Volume 20, Issue 4 (10-2022) Back to browse issues page
International Journal of Radiation Research
Persian site map - English site map - Created in 0.05 seconds with 50 queries by YEKTAWEB 4657